Overview
1. Therapy of neuromuscular disease - immunologic and neuromuscular facilitating agents for myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS).
2. Clinical trials in nerve, muscle and neuromuscular diseases
Current Appointments & Affiliations
Professor of Neurology
·
1980 - Present
Neurology, Neuromuscular Disease,
Neurology
Recent Publications
Authors' Reply.
Journal Article J Clin Neuromuscul Dis · March 1, 2025 Full text Link to item Cite275th ENMC international workshop: Seronegative myasthenia gravis: An update paradigm for diagnosis and management, 9-11 February 2024, Hoofddorp, the Netherlands.
Conference Neuromuscular disorders : NMD · November 2024 The 275th ENMC workshop on the diagnosis and management of seronegative myasthenia gravis (SNMG) was held on February 9-11, 2024. The participants included experts in the field of adult and pediatric MG together with patient representatives. This workshop ... Full text CiteAzathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply.
Journal Article Lancet Neurol · August 2024 Full text Link to item CiteRecent Grants
Defining the clinical phenotype and immunopathology of seronegative MG
ResearchKey Faculty · Awarded by Myasthenia Gravis Foundation · 2021 - 2023Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-Modifying Treatments for Myasthenia Gravis (MG)
Clinical TrialPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2017 - 2022Real World Outcomes of Surgical and Medical Management in Myasthenia Gravis
ResearchMentor · Awarded by American Academy of Neurology · 2019 - 2022View All Grants
Education, Training & Certifications
Harvard University ·
1964
M.D.